Modification of alternative splicing of Bcl-x Pre-mRNA in prostate and breast cancer cells: Analysis of apoptosis and cell death

Journal of Biological Chemistry

Volumn 276, Issue 19, 2001, Pages 16411-16417

  Mercatante, Danielle R ^a   Bortner, Carl D ^b   Cidlowski, John A ^b   Kole, Ryszard ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; ONCOLOGY; RNA;

APOPTOSIS;

CELLS;

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BCL XS; UNCLASSIFIED DRUG; BCL2L1 PROTEIN, HUMAN; ISOPROTEIN; RNA PRECURSOR; THAPSIGARGIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL DEATH; COLONY FORMATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; CELL CULTURE; COMPARATIVE STUDY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MINK CELL FOCUS-FORMING VIRUS;

ALTERNATIVE SPLICING; APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL DEATH; FEMALE; FLOW CYTOMETRY; GENES, REGULATOR; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS; THAPSIGARGIN; TRANSFECTION; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0035844238     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M009256200     Document Type: Article

References (47)

1. Adams, J. M., and Cory, S. (1998) Science 281, 1322-1326
2. Antonsson, B., and Martinou, J. C. (2000) Exp. Cell Res. 256, 50-57
3. Lowe, S. W., and Lin, A. W. (2000) Carcinogenesis 21, 485-495
4. Reed, J. C. (1999) J. Clin. Oncol. 17, 2941-2953
5. Shinoura, N., Yoshida, Y., Asai, A., Kirino, T., and Hamada, H. (1999) Oncogene 18, 5703-5713
6. Kawakami, K., Tsukuda, M., Mizuno, H., Nishimura, G., Ishii, A., and Hamajima, K. (1999) Anticancer Research 19, 3927-3932
7. Taylor, S. T., Hickman, J. A., and Dive, C. (2000) J. Natl. Cancer Inst. 92, 18-23
8. Liu, Q. Y., and Stein, C. A. (1997) Clin. Cancer Res. 3, 2039-2046
9. Han, J. S., Núñez, G., Wicha, M. S., and Clarke, M. F. (1998) Springer Semin. Immunopathol. 19, 279-288
10. Wang, D. G. (1999) Clin. Endocrinol. 51, 1-9
11. Mercatante, D., and Kole, R. (2000) Pharmacol. Ther. 85, 237-243
12. Jiang, Z. H., and Wu, J. Y. (1999) Proc. Soc. Exp. Biol. Med. 220, 64-72
13. Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Núñez, G., and Thompson, C. B. (1993) Cell 74, 597-608
14. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. (1998) Cancer Res. 58, 256-262
15. Reeve, J. G., Xiong, J., Morgan, J., and Bleehen, N. M. (1996) Br. J. Cancer 73, 1193-1200
16. Olopade, O. I., Adeyanju, M. O., Safa, A. R., Hagos, F., Mick, R., Thompson, C. B., and Recant, W. M. (1997) Cancer J. Sci. Am. 3, 230-237
17. Liu, R., Page, C., Beidler, D. R., Wicha, M. S., and Núñez, G. (1999) Am. J. Pathol. 155, 1861-1867
18. Schmitt, E., Cimoli, G., Steyaert, A., and Bertrand, R. (1998) Exp. Cell Res. 240, 107-121
19. Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., and Reed, J. C. (1996) Am. J. Pathol. 148, 1567-1576
20. Minn, A. J., Boise, L. H., and Thompson, C. B. (1996) J. Biol. Chem. 271, 6306-6312
21. Clarke, M. F., Apel, I. J., Benedict, M. A., Eipers, P. G., Sumantran, V., González-García, M., Doedens, M., Fukunaga, N., Davidson, B., Dick, J. E., Minn, A. J., Boise, L. H., Thompson, C. B., Wicha, M., and Núñez, G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11024-11028
22. Ealovega, M. W., McGinnis, P. K., Sumantran, V. N., Clarke, M. F., and Wicha, M. S. (1996) Cancer Res. 56, 1965-1969
23. Sumantran, V. N., Ealovega, M. W., Núñez, G., Clarke, M. F., and Wicha, M. S. (1995) Cancer Res. 55, 2507-2510
24. Sierakowska, H., Sambade, M. J., Agrawal, S., and Kole, R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 12840-12844
25. Sierakowska, H., Sambade, M. J., Schumperli, D., and Kole, R. (1999) RNA 5, 369-377
26. Wilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., and Kole, R. (1999) Neuromuscul. Disorders 9, 330-338
27. Friedman, K. J., Kole, J., Cohn, J. A., Knowles, M. R., Silverman, L. M., and Kole, R. (1999) J. Biol. Chem. 274, 36193-36199
28. Teixeira, C., Reed, J. C., and Pratt, M. A. C. (1995) Cancer Res. 55, 3902-3907
29. Philips, A., Chalbos, D., and Rochefort, H. (1993) J. Biol. Chem. 268, 14103-14108
30. Cohen, J. J. (1993) Immunol. Today 14, 126-130
31. Fiers, W., Beyaert, R., Declercq, W., and Vandenabeele, P. (1999) Oncogene 18, 7719-7730
32. Wyllie, A. H. (1980) Nature 284, 555-556
33. Sproat, B. S., and Lamond, A. I. (1993) in Antisense Research and Applications (Crooke, S. T., and Lebleu, B., eds) pp. 351-363, CRC Press, Inc., Boca Raton, FL
34. Stein, D., Foster, E., Huang, S. B., Weller, D., and Summerton, J. (1997) Antisense Nucleic Acid Drug Dev. 7, 151-157
35. Brown, J. M., and Wouters, B. G. (1999) Cancer Res. 59, 1391-1399
36. Sergeev, I. N., and Rhoten, W. B. (1998) Endocrine 9, 321-327
37. Qi, X. M., He, H., Zhong, H., and Distelhorst, C. W. (1997) Oncogene 15, 1207-1212
38. Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R., Lakatta, E. G., and Longo, D. L. (1999) Mol. Cell. Biol. 19, 5659-5674
39. Taylor, J. K., Zhang, Q. Q., Monia, B. P., Marcusson, E. G., and Dean, N. M. (1999) Oncogene 18, 4495-4504
40. Leech, S. H., Olie, R. A., Gautschi, O., Simoes-Wust, A. P., Tschopp, S., Haner, R., Hall, J., Stahel, R. A., and Zangemeister-Wittke, U. (2000) Int. J. Cancer 86, 570-576
41. Taylor, J. K., Zhang, Q. Q., Wyatt, J. R., and Dean, N. M. (1999) Nat. Biotechnol. 17, 1097-1100
42. Carrol, A. G., Voeller, H. J., Sugars, L., and Gelmann, E. P. (1993) Prostate 23, 123-134
43. Isaacs, W. B., Carter, B. S., and Ewing, C. M. (1991) Cancer Res. 51, 4716-4720
44. Nieves-Neira, W., and Pommier, Y. (1999) Int. J. Cancer 82, 396-404
45. Zapata, J. M., Krajewska, M., Krajewski, S., Huang, R. P., Takayama, S., Wang, H. G., Adamson, E., and Reed, J. C. (1998) Breast Cancer Res. Treat 47, 129-140
46. Zelphati, O., and Szoka, F. C. J. (1996) Pharm. Res. (N. Y.) 13, 1367-1372
47. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H. G., Irie, S., Fong, L., and Reed, J. C. (1994) Cancer Res. 54, 5501-5507